Your browser doesn't support javascript.
loading
Considerations in boosting COVID-19 vaccine immune responses.
Krause, Philip R; Fleming, Thomas R; Peto, Richard; Longini, Ira M; Figueroa, J Peter; Sterne, Jonathan A C; Cravioto, Alejandro; Rees, Helen; Higgins, Julian P T; Boutron, Isabelle; Pan, Hongchao; Gruber, Marion F; Arora, Narendra; Kazi, Fatema; Gaspar, Rogerio; Swaminathan, Soumya; Ryan, Michael J; Henao-Restrepo, Ana-Maria.
Afiliación
  • Krause PR; Office of Vaccines Research and Review, Food and Drug Administration, Silver Spring, MD, USA. Electronic address: philip.krause@fda.hhs.gov.
  • Fleming TR; Department of Biostatistics, University of Washington, Seattle, WA, USA.
  • Peto R; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Longini IM; Department of Biostatistics, University of Florida, Gainesville, FL, USA.
  • Figueroa JP; University of the West Indies, Mona, Jamaica.
  • Sterne JAC; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Cravioto A; Universidad Nacional Autónoma de México, DF, Mexico.
  • Rees H; Wits Reproductive Health and HIV Institute, Johannesburg, South Africa.
  • Higgins JPT; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Boutron I; Centre of Research in Epidemiology and Statistics (CRESS), Université de Paris, Paris, France.
  • Pan H; MRC Population Health Research Unit, University of Oxford, Oxford, UK.
  • Gruber MF; Office of Vaccines Research and Review, Food and Drug Administration, Silver Spring, MD, USA.
  • Arora N; The INCLEN Trust International, New Delhi, India.
  • Kazi F; World Health Organization, Geneva, Switzerland.
  • Gaspar R; World Health Organization, Geneva, Switzerland.
  • Swaminathan S; World Health Organization, Geneva, Switzerland.
  • Ryan MJ; World Health Organization, Geneva, Switzerland.
  • Henao-Restrepo AM; World Health Organization, Geneva, Switzerland. Electronic address: henaorestropa@who.int.
Lancet ; 398(10308): 1377-1380, 2021 10 09.
Article en En | MEDLINE | ID: mdl-34534516
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Inmunización Secundaria / Medicina Basada en la Evidencia / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans Idioma: En Revista: Lancet Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Inmunización Secundaria / Medicina Basada en la Evidencia / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans Idioma: En Revista: Lancet Año: 2021 Tipo del documento: Article